Symbiotec Pharmalab Limited
ListedMainboardHealthcare · NSE / BSE
Incorporated in 2002, Symbiotec Pharmalab Ltd. is a pharmaceutical and biotechnology company that develops and manufactures active pharmaceutical ingredients, nutritional ingredients, and specialty products for both domestic and international markets. The company focuses on research-based manufacturing, strong quality standards, and sustainable processes, serving industries like pharmaceuticals, nutraceuticals, and wellness with high-quality and innovative products. With over 30 years of experience, it has grown from a small lab-scale steroid API manufacturer into a large, fully integrated company with approvals from global authorities like the US FDA, EU-GMP, and Korea’s Ministry of Food and Drug Safety. As of June 30, 2025, the company operates two large-scale manufacturing facilities with a chemical synthesis capacity of 584.67 metric tonnes and fermentation capacity of 300 kilolitres.
Price Band
₹938 – ₹988
Issue Size
₹1778.64 L Cr
Lot Size
15 shares
GMP
₹185
+18.7%
Est. Listing
₹1173
at current GMP
Subscribed
75.06x
overall
Open
24 Aug 2026
Close
27 Aug 2026
Allotment
28 Aug 2026
Refund
29 Aug 2026
Demat Credit
30 Aug 2026
Listing
1 Sep 2026
Last updated 27 days ago
Official Registrar Verification
Symbiotec Pharmalab Limited Allotment Status
Designated Registrar: Link Intime India Private Limited
Allotment Date
28 Aug 2026
Basis finalization
Refunds Initiate
29 Aug 2026
Mandate release
Demat Credit
30 Aug 2026
Shares in demat
Listing Debut
1 Sep 2026
Trading begins
How to Check Symbiotec Pharmalab Limited IPO Allotment Status
- Click the Check on Registrar button above to visit Link Intime India Private Limited's allotment portal.
- Select Symbiotec Pharmalab Limited from the dropdown company list.
- Choose your lookup mode: PAN Number, Application Number, or DP Client ID.
- Enter your details accurately and solve the Captcha code.
- Click Submit / Search to view the number of shares applied and allotted to you.
About Symbiotec Pharmalab Limited Public Issue & Market Profile
Symbiotec Pharmalab Limited is bringing an initial public offering (IPO) in the Healthcare sector with an aggregate issue size of ₹1,77,86,442 Crores. The shares are offered at a price band of ₹938 to ₹988 per equity share on NSE and BSE. Currently, market analysts recommend evaluating the company's financial valuation, price-to-earnings (P/E) multiple, and peer comparison prior to submitting bids.
Public Issue & Allotment Procedure:
The public offer consists of a fresh issue and offer-for-sale structured under SEBI regulations. Bidding is open to Qualified Institutional Buyers (QIB), Non-Institutional Bidders (NII/HNI), and Retail Individual Investors (RII). Applications can be submitted online using ASBA or UPI mandate through certified stock brokers and net banking portals.
Official Allotment Timelines & Registrar Guidance:
Following the close of bidding on 2026-08-27, the basis of allotment is scheduled to be finalized on 2026-08-28. Investors can verify their application status online by submitting their PAN card number, Application Number, or DP Client ID on the registrar's official portal (Link Intime India Private Limited) or the BSE allotment checking window.
Frequently Asked Questions
What if my name is not showing on the registrar portal?
Allotment records are updated in batches. If the status is not yet available, please wait a few hours until the basis of allotment is fully finalized.
How will I receive the refund if I don't get allotment?
Since funds are blocked under ASBA/UPI, the bank will automatically release the blocked hold on your funds upon receipt of revocation instructions from the sponsor bank.